Prof. Dr. med. Thomas Hundsberger
Klinik für Neurologie (50%)
Klinik für Hämatologie und medizinische Onkologie (50%)
Ko-Leitung Zentrum für seltene Erkrankungen Ostschweiz (ZSK-O)
Interdisziplinäre Neuro-onkologische Ambulanz
Dozentur Universität St. Gallen (HSG)
Themenblockkoordinator Nervensystem im Joint Medical Master UZH/HSG
Leitende(r) Arzt/Ärztin
Neurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I
Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey
Lagler F, Karabul N, Rösler K, Hundsberger T, Gökce S, Mengel E, Hennermann J, Rohrbach M, Moder A, Huemer M. Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey. JIMD Rep 2019; 49:89-95.
17.07.2019Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey
17.07.2019JIMD Rep 2019; 49:89-95
Lagler Florian B, Karabul Nesrin, Rösler Kai M, Hundsberger Thomas, Gökce Seyfullah, Mengel Eugen, Hennermann Julia, Rohrbach Marianne, Moder Angelika, Huemer Martina
Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale
Hundsberger T, Schoser B, Leupold D, Rösler K, Putora P. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale. J Neurol 2019; 266:2010-2017.
18.05.2019Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale
18.05.2019J Neurol 2019; 266:2010-2017
Hundsberger Thomas, Schoser Benedikt, Leupold Daniela, Rösler Kai Michael, Putora Paul Martin
36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry
Scheidegger O, Leupold D, Sauter R, Findling O, Rösler K, Hundsberger T. 36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry. J Neurol 2018
19.09.201836-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry
19.09.2018J Neurol 2018
Scheidegger Olivier, Leupold Daniela, Sauter Rafael, Findling Oliver, Rösler Kai Michael, Hundsberger Thomas
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
Wirsching H, Riklin C, Felsberg J, Roth P, Jones D, Pfister S, Rushing E, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Weller M. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Ann Oncol 2018; 29:1423-1430.
01.06.2018Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
01.06.2018Ann Oncol 2018; 29:1423-1430
Wirsching H-G, Riklin C, Felsberg J, Roth P, Jones D T W, Pfister S, Rushing E J, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, von Moos R, Caparrotti F, Tabatabai G, Roelcke U, Hottinger A F, Jörger F, Schmid A, Plasswilm Ludwig, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger Thomas, Weller M
[A Rare Cause for Transient Aphasia after Conorary Angiography]
Schilling C, Weilenmann D, Diener S, Hundsberger T. [A Rare Cause for Transient Aphasia after Conorary Angiography]. Praxis (Bern 1994) 2018; 107:531-534.
03.04.2018[A Rare Cause for Transient Aphasia after Conorary Angiography]
03.04.2018Praxis (Bern 1994) 2018; 107:531-534
Schilling Carin, Weilenmann Daniel, Diener Suzie, Hundsberger Thomas
Fieber bei monoklonaler Gammopathie und Immunneuropathie – ein differenzialdiagnostischer Sple(e)n
Lüscher D, Diethelm M, Hundsberger T, Hitz F. Fieber bei monoklonaler Gammopathie und Immunneuropathie – ein differenzialdiagnostischer Sple(e)n. Praxis (Bern 1994) 2018; 107:329-333.
14.03.2018Fieber bei monoklonaler Gammopathie und Immunneuropathie – ein differenzialdiagnostischer Sple(e)n
14.03.2018Praxis (Bern 1994) 2018; 107:329-333
Lüscher Daniel, Diethelm Markus, Hundsberger Thomas, Hitz Felicitas
Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management
Astaras C, de Micheli R, Moura B, Hundsberger T, Hottinger A. Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management. Curr Neurol Neurosci Rep 2018; 18:3.
01.02.2018Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management
01.02.2018Curr Neurol Neurosci Rep 2018; 18:3
Astaras Christophoros, de Micheli Rita, Moura Bianca, Hundsberger Thomas, Hottinger Andreas F
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
Hottinger A, Bodmer A, Weber D, Schaller K, Mach N, Hundsberger T, Vargas M, Dunkel N, Squiban D, Espeli V, Ben Aissa A, Dietrich P. Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. Br J Cancer 2018
09.01.2018Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
09.01.2018Br J Cancer 2018
Hottinger A F, Bodmer A, Weber D C, Schaller K, Mach N, Hundsberger Thomas, Vargas M I, Dunkel N, Squiban D, Espeli V, Ben Aissa A, Dietrich P-Y
Herpes zoster induced predominant motor lumbal plexopathy in a lung cancer patient
Hundsberger T. Herpes zoster induced predominant motor lumbal plexopathy in a lung cancer patient. Austin J Neurol Disord Epilepsy 2017; 4:1036.
08.12.2017Herpes zoster induced predominant motor lumbal plexopathy in a lung cancer patient
08.12.2017Austin J Neurol Disord Epilepsy 2017; 4:1036
Hundsberger Thomas
Heart rate variability decreases after 3 months of sustained treatment with fingolimod
Vehoff J, Haegele-Link S, Humm A, Mueller S, Sauter R, Tettenborn B, Hundsberger T. Heart rate variability decreases after 3 months of sustained treatment with fingolimod. J Neurol 2017; 264:2313-2317.
09.10.2017Heart rate variability decreases after 3 months of sustained treatment with fingolimod
09.10.2017J Neurol 2017; 264:2313-2317
Vehoff Jochen, Haegele-Link Stefan, Humm Andrea, Mueller Stefanie Karin, Sauter Rafael, Tettenborn Barbara, Hundsberger Thomas
Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis
Panje C, Glatzer M, von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L, Putora P. Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Med Res Methodol 2017; 17:123.
16.08.2017Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis
16.08.2017BMC Med Res Methodol 2017; 17:123
Panje Cédric, Glatzer Markus, von Rappard Joscha, Rothermundt Christian, Hundsberger Thomas, Zumstein Valentin, Plasswilm Ludwig, Putora Paul Martin
Unilateral tongue myokymia - A rare topodiagnostic sign of different clinical conditions
Leupold D, Schilg-Hafer L, Felbecker A, Kim O, Tettenborn B, Hundsberger T. Unilateral tongue myokymia - A rare topodiagnostic sign of different clinical conditions. J Clin Neurosci 2017
29.07.2017Unilateral tongue myokymia - A rare topodiagnostic sign of different clinical conditions
29.07.2017J Clin Neurosci 2017
Leupold Daniela, Schilg-Hafer Lenka, Felbecker Ansgar, Kim Olaf Chan-Hi, Tettenborn Barbara, Hundsberger Thomas
Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial
Vehoff J, Hägele-Link S, Humm A, Müller S, Sauter R, Tettenborn B, Hundsberger T (2017). Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial.
25.06.2017Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial
25.06.20173rd EAN Congress
Vehoff Jochen, Hägele-Link Stefan, Humm Andrea, Müller Stefanie, Sauter Rafael, Tettenborn Barbara, Hundsberger Thomas
Bevacizumab: Zankapfel der Glioblastomtherapie
Hundsberger T, Weller M. Bevacizumab: Zankapfel der Glioblastomtherapie. Praxis (Bern 1994) 2017; 106:415-420.
27.04.2017Bevacizumab: Zankapfel der Glioblastomtherapie
27.04.2017Praxis (Bern 1994) 2017; 106:415-420
Hundsberger Thomas, Weller Michael
Angiogenesis inhibitors in tackling recurrent glioblastoma
Hundsberger T, Reardon D, Wen P. Angiogenesis inhibitors in tackling recurrent glioblastoma. Expert Rev Anticancer Ther 2017
24.04.2017Angiogenesis inhibitors in tackling recurrent glioblastoma
24.04.2017Expert Rev Anticancer Ther 2017
Hundsberger Thomas, Reardon David A, Wen Patrick Y
3-year follow-up data of the Swiss Pompe Registry-analysis of the first 7 patients
Hundsberger T (2017). 3-year follow-up data of the Swiss Pompe Registry-analysis of the first 7 patients - T. Hundsberger, O. Scheidegger, D. Leupold, O. Findling, K. M. Roesler. Präsentiert bei: 23. Kongress des wissenschaftlichen Beirates der Deutschen Gesellschaft für Muskelerkrankungen, München, Deutschland
02.03.20173-year follow-up data of the Swiss Pompe Registry-analysis of the first 7 patients
02.03.201723. Kongress des wissenschaftlichen Beirates der Deutschen Gesellschaft für Muskelerkrankungen
Hundsberger Thomas
Spontaneous multifocal cervical liquor leakage causing an intracranial hypotension syndrome
Hundsberger T (2016). Spontaneous multifocal cervical liquor leakage causing an intracranial hypotension syndrome.
30.12.2016Spontaneous multifocal cervical liquor leakage causing an intracranial hypotension syndrome
30.12.2016Gemeinsame Jahrestagung der Schweizerischen Neurologischen Gesellschaft (178. Tagung) und der Schweizerischen Gesellschaft für Klinische Neurophysiologie und SVEPTA Fortbildung
Hundsberger Thomas
Diagnostischer Stellenwert der Nervensonographie beim Karpaltunnelsyndrom
Hundsberger T. Diagnostischer Stellenwert der Nervensonographie beim Karpaltunnelsyndrom - Nervenengpasssyndrom. InFo Neurologie & Psychiatrie 2016; 14:12-15.
30.11.2016Diagnostischer Stellenwert der Nervensonographie beim Karpaltunnelsyndrom
30.11.2016InFo Neurologie & Psychiatrie 2016; 14:12-15
Hundsberger Thomas
Neuronal ganglia as a cause of peripheral nerve lesion
Leupold D, Schilg-Hafer L, Felbecker A, Tettenborn B, Hundsberger T (2016). Neuronal ganglia as a cause of peripheral nerve lesion.
13.09.2016Neuronal ganglia as a cause of peripheral nerve lesion
13.09.2016SFCNS
Leupold Daniela, Schilg-Hafer Lenka, Felbecker Ansgar, Tettenborn Barbara, Hundsberger Thomas
Anaplastische Gliome und ältere Glioblastompatienten
Hundsberger T (2016). Anaplastische Gliome und ältere Glioblastompatienten - Verbesserte Überlebenszeit durch Therapieintensivierung.
01.08.2016Anaplastische Gliome und ältere Glioblastompatienten
01.08.2016ASCO annual meeting 2016
Hundsberger Thomas